Bacterial food web may be key to cystic fibrosis

by Anne Ju

(Medical Xpress)—Cystic fibrosis patients suffer from chronic bacterial infections and thick mucous in their lungs, due largely to a combination of microbial infections and resulting inflammation. A common pathogen, Pseudomonas aeruginosa, which can lay dormant in healthy individuals, becomes virulent in the lungs of cystic fibrosis patients, and Cornell biological engineers think they might know why.

They have shown that P. aeruginosa virulence is "turned on" when it feeds on a particular fermentation product called 2,3 butanediol, demonstrating a direct metabolic relationship between fermenting bacteria and P. aeruginosa. This understanding could lead to more effective treatments for cystic ; rather than the use of antibiotics, disrupting P. aeruginosa's flow of preferred food could be key to preventing cystic fibrosis-related infections in the lungs.

The research was led by Lars Angenent, associate professor of biological and environmental engineering. A paper, along with a related one by San Diego State University researchers, was published online Jan. 9 in the International Society for Microbial Ecology Journal.

Angenent et al. had previously used bioreactors to show that the presence of 2,3 butanediol promotes cross-feeding between P. aeruginosa and fermenting bacteria, including Enterobacter aerogenes, which makes 2,3 butanediol as a fermentation byproduct.

They are now applying their knowledge of this mutually beneficial microbial relationship to shed light on the microbial environment of lungs affected by . In this work, they again used bioreactors to observe the virulence of P. aeruginosa as it fed on both 2,3 butanediol and glucose; the glucose did not cause virulence, while with the 2,3 butanediol, the bacteria became significantly more virulent.

Scientists already knew that P. aeruginosa plays a key role in sickening patients, but the exact microbial interactions and subsequent inflammatory responses that lead to the symptoms have not been well understood.

Because 2,3 butanediol is the substrate, or food, for P. aeruginosa, 2,3 butanediol is the key in the metabolic relationship between different bacteria.

Their relationship results in higher concentrations of phenazines, which are chemicals produced by P. aeruginosa that interact with the fermenter, and are part of the cascade of events that leads to the pathogen's increased virulence, such as the formation of biofilms that increase lung symptoms in patients. The phenazines combine with oxygen to create free radical compounds, which kill other microbes and cause stress for host cells.

"The signaling is switched on because of the 2,3 butanediol," Angenent explained. "However, the exact mechanism is still unknown."

Understanding why P. aeruginosa does well in the lungs of , and looking at ways to cut off its preferred food supply within that system, could lead to ways to treat the disease, the scientists say.

More information: "Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa." Arvind Venkataraman, Miriam A Rosenbaum, Jeffrey J Werner, Stephen C Winans, Largus T Angenent. The ISME Journal advance online publication, 9 January 2014; DOI: 10.1038/ismej.2013.232

Related Stories

Microbe efficiencies could make better fuel cells

Jun 10, 2011

(PhysOrg.com) -- Like mutual back-scratching, two common bacteria involved in what was thought to be only a marginally important relationship actually help each other thrive when grown together in bioreactors, ...

Inhaler approved for cystic fibrosis patients

Mar 25, 2013

(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...

Recommended for you

Growing a blood vessel in a week

17 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

20 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments